Perez, J. R., Ye, L. F., Repetto, M., Daher, S. N., Lomibao, M., Falcon, C., Drilon, A. E., Arbour, K. C. (2026). Impact of KRAS co-mutations on the efficacy of durvalumab in patients with locally advanced non–small cell lung cancer (LA-NSCLC) treated with concurrent chemoradiotherapy (ChRT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8550